Importantly, in vivo treatment with a pharmacological chaperon, isofagomine, known to enhance GBA1 function in Gaucher’s disease fibroblasts, suppressed the increased p38 activation and TNF-α formation in brain tissues, and extended life span [26]. This evidence concerns the gene MAPK14 and Gaucher disease.